Medikit Co.,Ltd.

Tokyo Stock Exchange 7749.T

Medikit Co.,Ltd. Net Income Margin for the year ending March 31, 2024: 14.05%

Medikit Co.,Ltd. Net Income Margin is 14.05% for the year ending March 31, 2024, a 5.96% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.
  • Medikit Co.,Ltd. Net Income Margin for the year ending March 31, 2023 was 13.26%, a -10.83% change year over year.
  • Medikit Co.,Ltd. Net Income Margin for the year ending March 31, 2022 was 14.87%, a 7.99% change year over year.
  • Medikit Co.,Ltd. Net Income Margin for the year ending March 31, 2021 was 13.77%, a -5.16% change year over year.
  • Medikit Co.,Ltd. Net Income Margin for the year ending March 31, 2020 was 14.52%.
Key data
Date Net Income Margin EBITDA Margin EBIT Margin EBITDA
Market news
SV Wall Street
Tokyo Stock Exchange: 7749.T

Medikit Co.,Ltd.

CEO Mr. Hiroaki Nakajima
IPO Date June 28, 2005
Location Japan
Headquarters 1-13-2, Yushima
Employees 966
Sector Health Care
Industries
Pharmaceuticals Medical Instruments
Description

Medikit Co.,Ltd. engages in the manufacture and sale of vascular access medical devices. The company offers IV catheters, such as Supercath 5, Supercath Z3V, and Supercath Ztu-V; hemodialysis products, including Supercath PRO, Supercath NEO, and Supercath Clampcath; and intervention products comprising Supersheath and Mongoose. Its products are used in anesthetic departments, operating theaters, ICUs, and dialysis and cardiology units. The company markets its products through distributors in approximately 20 countries and territories in the European Union and on the American continent. Medikit Co.,Ltd. was founded in 1973 and is headquartered in Tokyo, Japan.

StockViz Staff

February 1, 2025

Any question? Send us an email